As part of RECOMB's mission to advance genetherapy for RAG1-SCID, we have released a new flyer to promote and support patient recruitment for the clinical study. Now available in Dutch, German, Polish, Turkish, and Italian and Spanish, the flyer is designed to reach and connect with patients across Europe. Access the flyers here